ALISON ALLEN: Open Payments
NPI 1285780874 · BASALT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 30 payments from 15 companies in 2025. Trend: 2023 $893 · 2024 $1,012 · 2025 $869
Food & beverage: $595Speaker / faculty: $274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $315 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| EMD Serono, Inc. | 2 | $55 |
| SK Life Science, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Amgen Inc. | 2 | $48 |
| C2N Diagnostics, LLC | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| PFIZER INC. | 1 | $26 |
| Neurelis, Inc. | 1 | $26 |
Products named: KESIMPTA, AMYVID, UPLIZNA, PRECIVITYAD2, INGREZZA, NURTEC ODT, VALTOCO, VYVGART HYTRULO.
Industry payments across CO — which companies pay providers there.
